REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biomlife Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Biomlife Sp. z o.o. Profile Updated: August 10, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Biomlife Sp. z o.o. is a company based in Poland, with its head office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The company was established on May 09, 2022. Over the same period, its total assets decreased by 25.75%.

Headquarters
Ul. Aleja Wojska Polskiego 50/54
Warsaw; Mazowieckie; Postal Code: 01-554

Contact Details: Purchase the Biomlife Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Biomlife Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Biomlife Sp. z o.o. report to view the information.
Incorporation Date:
May 09, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
66.67%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Biomlife Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
68.33%▲
EBITDA
68.33%▲
Net Profit (Loss) for the Period
68.33%▲
Total Assets
-25.75%▼
Total Equity
-200.21%▼
Return on Equity (ROE)
-565.49%▼
Debt/Equity
96.97%▲

Similar companies

Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
 
"Novo Nordisk Pharma" Sp. z o.o.
Selvita S.A.
 
Polpharma Biologics S.A.
Instytut Lacznosci - Panstwowy Instytut Badawczy
 
Kcr S.A.
Windprojekt Sp. z o.o.
 
Wilandt Institute
Wet-Family Sp. z o.o.
 
Wekzmed Sp. z o.o.
Warsaw Genomics Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo